Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
[68Ga]DATA5m.SA.FAPi
- Development stage
- Unknown
- Lead developer
- Medical University of Vienna
- Modality
- Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Positron Emitters → Radiopharmaceuticals, Small Molecules
- Administration
- Intravenous
01
Overview
[68Ga]DATA5m.SA.FAPi is a gallium-68 labeled radiopharmaceutical diagnostic imaging agent targeting fibroblast activation protein (FAP). It consists of a squaric acid (SA) coupled hybrid chelator (DATA5m) conjugated to a FAP inhibitor (FAPi) pharmacophore derived from UAMC1110. The DATA5m chelator allows for rapid, quantitative radiolabeling with gallium-68 at room temperature, facilitating "instant kit-type" preparation. It is developed for positron emission tomography (PET) imaging of cancer-associated fibroblasts (CAFs) in various epithelial carcinomas (such as prostate cancer, glioblastoma, non-small cell lung cancer, and pancreatic cancer) as well as disease-associated fibroblasts in benign fibrotic conditions (including pulmonary fibrosis, cardiac fibrosis, and Crohn's disease-associated bowel wall fibrosis).
- Other names
- 68Ga-DATA5m.SA.FAPIgallium 68 DATA5m.SA.FAPIgallium68 DATA5m.SA.FAPIgallium-68 DATA5m.SA.FAPI
02
Targets
FAP (Fibroblast activation protein alpha)
Beyond the preview
Go deeper on [68Ga]DATA5m.SA.FAPi.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on [68Ga]DATA5m.SA.FAPi.